Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein.
Starling JJ, Shepard RL, Cao J, Law KL, Norman BH, Kroin JS, Ehlhardt WJ, Baughman TM, Winter MA, Bell MG, Shih C, Gruber J, Elmquist WF, Dantzig AH.
Starling JJ, et al.
Adv Enzyme Regul. 1997;37:335-47. doi: 10.1016/s0065-2571(96)00021-0.
Adv Enzyme Regul. 1997.
PMID: 9381979